India  

DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine

IndiaTimes Thursday, 30 July 2020 ()
A CDSCO expert panel has sought clarifications from Serum Institute of India (SII) over its application to the DCGI seeking permission for conducting phase 2 and 3 human clinical trials of the Oxford vaccine candidate for COVID-19, official sources said on Wednesday. On Wednesday evening, SII submitted a revised protocol for conducting the trials to the DCGI.
0
shares
ShareTweetSavePostSend
 
Video Credit: Veuer - Published
News video: Proposed COVID-19 Vaccine Becomes First in U.S. to Reach Phase 3 Test Trials

Proposed COVID-19 Vaccine Becomes First in U.S. to Reach Phase 3 Test Trials 00:57

A proposed coronavirus vaccine becomes the first in the U.S. to start phase three trials. Veuer’s Justin Kircher has the story.

💡 newsR Knowledge: Other News Mentions

Drug Controller General of India organization

COVID-19 medicine: Lupin launches Favipiravir in India at Rs 49 per tablet

Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use on COVID-19 patients as a potential treatment
DNA
COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR [Video]

COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR

Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials which are starting within a week at 17 sites. Earlier, the Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford vaccine.

Credit: ANI    Duration: 02:24Published

Serum gets DCGI nod for Phase 2 & 3 trials

India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford..
IndiaTimes
COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again [Video]

COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again

The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford University. According to the World Health Organization (WHO), a number of vaccines are now in phase-3 clinical trials. Meanwhile, Chief Minister of Madhya Pradesh Shivraj Singh Chouhan on August 03 again tested positive for COVID-19 on the 10th day of his admission to hospital. Today, Andhra Pradesh reported 7,822 new COVID-19 cases, taking the total number of coronavirus cases in the state 1,66,586. Uttar Pradesh reported 4,473 new COVID-19 cases and 50 deaths in the last 24 hours, taking active cases to 40,191 and death toll to 1,778. Tamil Nadu reported 5,609 new COVID-19 cases and 109 deaths in the last 24 hours, taking total cases to 2,63,222 including 2,02,283 discharges and 4,241 deaths.

Credit: ANI    Duration: 01:38Published

DCGI nod to Serum Institute of India for phase 2 & 3 clinical trials of Oxford Covid-19 vaccine

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India for conducting phase 2 and 3 human clinical trials of the Oxford..
IndiaTimes

University of Oxford University of Oxford Collegiate research university in Oxford, England

Boris Johnson holds socially distanced Cabinet meeting [Video]

Boris Johnson holds socially distanced Cabinet meeting

Boris Johnson has assembled his Cabinet in person for the first time in four months, as the Government presses ahead with plans to secure millions of doses of a potential Covid-19 vaccine.Senior ministers are meeting in the Foreign and Commonwealth Office rather than the smaller Cabinet room in Downing Street to allow for proper social distancing.It comes after a study suggested a Covid-19 vaccine being developed by the University of Oxford was safe and induces an immune reaction, which was branded “encouraging” by the scientific community.

Credit: PA - Press Association STUDIO    Duration: 03:22Published
How does the Oxford Covid-19 vaccine work? [Video]

How does the Oxford Covid-19 vaccine work?

Human trials of the coronavirus vaccine candidate being developed at the University of Oxford suggest it is safe and induces an immune response to Covid-19.Early results indicate the jab could provide double protection – generating an immune response which stimulates the body to produce both an antibody and T-cell response.But what does the vaccine do, how does it work, and what happens next?

Credit: PA - Press Association STUDIO    Duration: 01:40Published
Oxford coronavirus team 'hopeful' a number of vaccines will be developed [Video]

Oxford coronavirus team 'hopeful' a number of vaccines will be developed

Professor Teresa Lambe, a key part of the vaccine development team at the University of Oxford, is hopeful that a number of coronavirus vaccines can be developed.

Credit: PA - Press Association STUDIO    Duration: 00:47Published
How might the coronavirus vaccine work? [Video]

How might the coronavirus vaccine work?

Human trials of the coronavirus vaccine candidate being developed at the University of Oxford are reported to be promising.It is thought that early results indicate the jab could provide double protection – generating an immune response which stimulates the body to produce both antibodies and “killer T-cells”.

Credit: PA - Press Association STUDIO    Duration: 01:54Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Serum Institute of India enters into partnership to accelerate manufacture, delivery of Covid vaccines for India

The Serum Institute of India (SII) has entered into a new landmark partnership with Gavi, the Vaccine Alliance and the Bill and Melinda Gates Foundation, to..
IndiaTimes

SII enters into new partnership to accelerate manufacture, delivery of Covid-19 vaccines for India

The Serum Institute of India (SII) has entered into a new landmark partnership with Gavi, the Vaccine Alliance and the Bill and Melinda Gates Foundation, to..
IndiaTimes
Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR [Video]

Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR

At present country has three Indian COVID-19 vaccines which are in different phases of clinical testing, said Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava on Tuesday. Addressing a press conference in the national capital, he said, "At the present moment, we have three Indian vaccines which are in different phases of clinical testing. The 2 vaccines- Bharat Biotech vaccine and DNA vaccine of Zydus Cadila have completed phase 1 and will begin phase 2 while third is Oxford vaccine." "Oxford vaccine, being manufactured by Serum Institute of India (SII) got approval for phase 2 and 3 clinical trials, which are starting within a week at 17 sites," he added. Dr Bhargava, however, said that social distancing and proper hygiene are the best "vaccine" available now and even after. "Physical Distancing, wearing a mask, proper hand hygiene are the best vaccine available at the moment and even after. We will have to continue with these measures," he said. India has so far recorded over 18 lakh cases and more than 38,900 deaths.

Credit: HT Digital Content    Duration: 06:42Published

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Officials Concerned With Russia’s COVID Vaccine [Video]

Officials Concerned With Russia’s COVID Vaccine

Officials Concerned With Russia’s COVID Vaccine

Credit: Wochit News    Duration: 00:26Published

Cry of privacy breach as Kerala cops tap call records of Covid patients

Kerala, whose scientific contact-tracing strategy in the initial weeks of the pandemic became a model for others to follow, has now worked up an ethical and..
IndiaTimes
Covid update: India's 10 lakh gap; New Zealand polls under cloud; WB lockdown [Video]

Covid update: India's 10 lakh gap; New Zealand polls under cloud; WB lockdown

From the gap between India's active and discharged cases increasing to almost 10 lakh, to another member of Narendra Modi's cabinet testing positive for infection - here are the top news updates on the Covid-19 pandemic. Shripad Yesso Naik is the fifth Union minister to test positive. Home minister Amit Shah was the first member of the Union cabinet to be infected. Naik who is the Minister of State (Independent Charge) of Ministry of Ayurved, Yoga, Naturopathy, Unani, Siddha & Homoeopathy (AYUSH), and Minister of State in the Ministry of Defence, is in home isolation. In Maharashtra, over 11,300 police personnel have so far been infected. While the death toll among Maharashtra cops has crossed 120, over 9,100 have recovered, and there are 2,000-plus active cases. In West Bengal, the state government withdrew the order regarding complete lockdown on August 28. However, lockdown orders remain in operation for August 20, 21, 27 and 31. India's total case tally has crossed 23.29 lakh, while the death toll has crossed 46,000. Over 16.39 lakh patients have been discharged so far. In international news, the discovery of a new case after 102 days in New Zealand has led the Prime Minister, Jacinda Ardern, to say that postponement of the upcoming general elections is a possibility. Meanwhile, the Russian government said that the first batch of its Covid vaccine is likely to be released within two weeks. Russia has become the first country to declare a vaccine ready for use. Watch the full video for more updates regarding the spread of the Sars-CoV-2 coronavirus.

Credit: HT Digital Content    Duration: 02:26Published
Barcelona player tests positive for COVID-19 [Video]

Barcelona player tests positive for COVID-19

A Barcelona player has tested positive for the novel coronavirus after reporting back for pre-season training, the La Liga side said in a statement on Wednesday (August

Credit: Reuters - Sports    Duration: 02:15Published
216 police personnel resume duty after conquering COVID-19 in Hyderabad [Video]

216 police personnel resume duty after conquering COVID-19 in Hyderabad

Hyderabad police personnel reported back to duty after recovering from coronavirus. At least 216 police personnel have come back on duty. They have received guard of honor. Police Commissioner Anjani Kumar also came to encourage the officials.

Credit: ANI    Duration: 01:33Published

You Might Like


Related videos from verified sources

Mexico hosting COVID-19 vaccine trials [Video]

Mexico hosting COVID-19 vaccine trials

Mexico will be a testing ground for multiple coronavirus vaccine trials. The country's foreign ministry says they have signed agreements with international pharmaceutical companies.

Credit: KTNV Channel 13 Las Vegas     Duration: 00:17Published
Covid vaccine: Why India won't take Russia's Sputnik V right now | Oneindia News [Video]

Covid vaccine: Why India won't take Russia's Sputnik V right now | Oneindia News

Russia claims that many countries have placed an order for the world's 'first' Covid vaccine that it has developed. But, it is unlikely that this vaccine will be made available in India. For this 2..

Credit: Oneindia     Duration: 01:28Published
Federal Government To Buy 100 Million Doses Of Moderna's Coronavirus Vaccine [Video]

Federal Government To Buy 100 Million Doses Of Moderna's Coronavirus Vaccine

WBZ TV's Kate Merrill reports.

Credit: WBZ CBS Boston     Duration: 00:20Published

Related news from verified sources

Hit by COVID cess, consumers downgrading to lower priced liquor

Hit by the steep price increase in wine, beer and spirits due to COVID cess, consumers in many states are downgrading to lower-priced alcoholic beverages,...
Mid-Day

COVID-19: Involve citizens in fight against coronavirus in Maharashtra, says Uddhav Thackeray

Maharashtra Chief Minister Uddhav Thackeray on Thursday said all cities in the state should set up 'corona vigilance committees',to involve participation of...
Mid-Day

World witnessing how one of the most successful battles against COVID-19 is being fought in India: Amit Shah

Union Home Minister Amit Shah on Sunday said that the whole world was appreciating India's successful fight against the COVID-19 pandemic. Speaking ahead of the...
Mid-Day


Tweets about this